SI-BONE, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SI-BONE, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $438.00K, a 34.14% decline year-over-year.
- SI-BONE, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $34.00K, a 66.99% decline year-over-year.
- SI-BONE, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $11.00K, a 92.90% decline year-over-year.
- SI-BONE, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $665.00K, a 118.75% increase year-over-year.
- SI-BONE, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $1.17M, a 105.09% increase from fiscal 2024.
- SI-BONE, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $570.00K, a 87.00% decline from fiscal 2023.
- SI-BONE, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $4.39M, a 1057.26% increase from fiscal 2022.
- SI-BONE, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $379.00K, a 85.22% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $438.00K 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $34.00K 10-Q · filed 2026-08-04 | |
| 2025-12-31 | $1.17M 10-K · filed 2026-02-24 | |
| 2025-09-30 | $11.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $665.00K 10-Q · filed 2026-08-04 | |
| 2025-03-31 | $103.00K 10-Q · filed 2026-08-04 | |
| 2024-12-31 | $570.00K 10-K · filed 2026-02-24 | |
| 2024-09-30 | $155.00K 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $304.00K 10-Q · filed 2025-11-10 | |
| 2024-03-31 | $105.00K 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $4.39M 10-K · filed 2026-02-24 | |
| 2023-09-30 | $229.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $3.52M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $520.00K 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $379.00K 10-K · filed 2025-02-25 | |
| 2022-09-30 | $106.00K 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $30.00K 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $169.00K 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $2.56M 10-K · filed 2023-03-02 | |
| 2021-09-30 | $1.08M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $650.00K 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $601.00K 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $1.46M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $628.00K 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $185.00K 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $174.00K 10-Q · filed 2021-11-09 | |
| 2019-12-31 | $1.49M 10-K · filed 2021-03-10 | |
| 2019-09-30 | $611.00K 10-Q · filed 2020-11-03 | |
| 2019-06-30 | $442.00K 10-Q · filed 2020-11-03 | |
| 2019-03-31 | $125.00K 10-Q · filed 2020-11-03 | |
| 2018-12-31 | $1.14M 10-K · filed 2020-03-11 | |
| 2018-09-30 | $707.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $190.00K 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $18.00K 10-Q · filed 2019-11-12 | |
| 2017-12-31 | $383.00K 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |